文献速递鼻科

过敏性与非过敏性鼻炎患者的鼻部过敏原反应阳性:系统综述

Positive allergen reaction in allergic and nonallergic rhinitis: a systematic review.
PubMed 文献 · Int Forum Allergy Rhinol · 2017-07-20

该系统综述检索EMBASE和Medline至2015年12月8日,纳入46项研究,评估过敏性与非过敏性鼻炎患者鼻过敏原激发试验的阳性率。过敏性鼻炎患者鼻部过敏原反应概率为86.3%,非过敏性鼻炎为24.7%;以主观点定义的阳性率高于客观终点。

要点

  • 非过敏性鼻炎患者中24.7%存在鼻部过敏原反应,提示局部过敏性可能。
  • 花粉反应性最高,粉尘最低,主客观终点影响阳性率判定。
  • SPT或sIgE定义的过敏性鼻炎中13.7%可能存在不准确致敏或非过敏性病因。

核心结论

  • 在既往被认为非过敏性的患者中,26.5%显示局部过敏原反应性;而SPT或sIgE定义的过敏性鼻炎中,13.7%可能为不准确致敏或非过敏性病因。

研究设计与样本

  • 系统综述与Meta分析,检索EMBASE和Medline至2015年12月8日,纳入46项提供AR或NAR患者鼻过敏原激发试验原始数据的研究。

主要发现

  • 鼻过敏原反应概率在AR人群为86.3%(95% CI 84.4-88.1),在NAR人群为24.7%(95% CI 22.3-27.2)。
  • 花粉反应性在AR为97.1%(95% CI 94.2-99.2),在NAR为47.5%(95% CI 34.8-60.4);粉尘在AR为79.1%(95% CI 76.4-81.6),在NAR为12.2%(95% CI 9.9-14.7)。
  • 以主观终点定义NAPT阳性时,AR为91.0%(95% CI 86.6-94.8),NAR为30.2%(95% CI 22.9-37.9);以客观终点定义时,AR为80.8%(95% CI 76.8-84.5),NAR为14.1%(95% CI 11.2-17.2)。

临床怎么用

  • 对既往诊断非过敏性鼻炎的患者,可考虑鼻过敏原激发试验以识别局部过敏反应。
  • NAPT结果解读需注意所用终点定义,主观终点阳性率高于客观终点。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The diagnosis of allergic rhinitis (AR) is based on cutaneous and serological assessment to determine immunoglobulin E (IgE)-mediated disease. However, discrepancies between these tests and nasal provocation exist. Patients diagnosed as non-allergic rhinitis (NAR) but with positive nasal allergen provocation test (NAPT) may represent a local allergic condition or entopy, still suitable to allergy interventions. The objective of this study was to determine the frequency of nasal reactivity toward allergens among AR and NAR patients, and to describe the diagnostic characteristics of NAPT methodologies. METHODS: EMBASE (1947-) and Medline (1946-) were searched until December 8, 2015. A search strategy was used to identify studies on AR or NAR patients subjected to diagnostic local nasal provocation. All studies providing original NAPT data among the AR or NAR population were included. Meta-analysis of proportion data was presented as a weighted probability % (95% confidence interval [CI]). RESULTS: The search yielded 4504 studies and 46 were included. The probability of nasal allergen reactivity for the AR population was 86.3% (95% CI, 84.4 to 88.1) and in NAR was 24.7% (95% CI, 22.3 to 27.2). Reactivity was high with pollen for both AR 97.1% (95% CI, 94.2 to 99.2) and NAR 47.5% (95% CI, 34.8 to 60.4), and lowest with dust for both AR 79.1% (95% CI, 76.4 to 81.6) and NAR 12.2% (95% CI, 9.9 to 14.7). NAPT yielded high positivity when defined by subjective end-points: AR 91.0% (95% CI, 86.6 to 94.8) and NAR 30.2% (95% CI, 22.9 to 37.9); and lower with objective end-points: AR 80.8% (95% CI, 76.8 to 84.5) and NAR 14.1% (95% CI, 11.2 to 17.2). CONCLUSION: Local allergen reactivity is demonstrated in 26.5% of patients previously considered non-allergic. Similarly, AR, when defined by skin-prick test (SPT) or serum specific IgE (sIgE), may lead to 13.7% of patients with inaccurate allergen sensitization or non-allergic etiologies.

来源:Int Forum Allergy Rhinol,查看原文。版权归原作者所有。

引用

  1. Hamizan AW, Rimmer J, Alvarado R, et al. Positive allergen reaction in allergic and nonallergic rhinitis: a systematic review. Int Forum Allergy Rhinol. 2017. PMID: 28727909. doi:10.1002/alr.21988

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。